Revenue (Tables)

9 Months Ended

Sep. 30, 2021

Revenue

Schedule of revenues disaggregated by Group, end customer geographical location and timing of recognition

The following table presents the Company’s revenues by Group and End Customer Geography (dollars in millions):

	Three Months Ended September 30,						Nine Months Ended September 30,
	2021			2020			2021			2020
Revenue by Group:
Bruker BioSpin	$	186.5		$	152.1		$	494.4		$	398.1
Bruker CALID		194.2			171.3			579.9			444.5
Bruker Nano		174.9			147.1			504.6			392.7
BEST		57.0			43.8			166.0			134.8
Eliminations		(3.7	)		(2.9	)		(10.5	)		(10.1	)
Total revenue	$	608.9		$	511.4		$	1,734.4		$	1,360.0
	Three Months Ended September 30,						Nine Months Ended September 30,
	2021			2020			2021			2020
Revenue by End Customer Geography:
United States	$	163.2		$	120.1		$	442.0		$	332.1
Germany		55.5			50.4			186.4			134.9
Rest of Europe		155.4			142.9			459.9			357.7
Asia Pacific		191.6			160.0			525.8			433.3
Other		43.2			38.0			120.3			102.0
Total revenue	$	608.9		$	511.4		$	1,734.4		$	1,360.0

Revenue for the Company recognized at a point in time versus over time is as follows (dollars in millions):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Revenue recognized at a point in time	$	530.8	$	442.2	$	1,503.0	$	1,174.0
Revenue recognized over time		78.1		69.2		231.4		186.0
Total revenue	$	608.9	$	511.4	$	1,734.4	$	1,360.0